Virtus ETF Advisers LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$76,301
-26.3%
1,681
-8.8%
0.05%
-24.6%
Q2 2023$103,522
+13.5%
1,844
-8.6%
0.06%
+22.0%
Q1 2023$91,229
-19.6%
2,017
-27.7%
0.05%
-15.3%
Q4 2022$113,454
-3.0%
2,791
+55.5%
0.06%
+25.5%
Q3 2022$117,000
+8.3%
1,795
+0.6%
0.05%
+17.5%
Q2 2022$108,000
-17.6%
1,784
-14.3%
0.04%
-32.2%
Q1 2022$131,000
-21.6%
2,081
-5.5%
0.06%
-6.3%
Q4 2021$167,000
-9.2%
2,203
+34.0%
0.06%
-22.2%
Q3 2021$184,000
-34.5%
1,644
-5.4%
0.08%
-30.2%
Q2 2021$281,000
+15.2%
1,737
-13.3%
0.12%
+12.6%
Q1 2021$244,000
-18.9%
2,003
+1.9%
0.10%
-17.6%
Q4 2020$301,000
-30.2%
1,966
-61.9%
0.12%
-44.7%
Q3 2020$431,000
+0.5%
5,155
-11.8%
0.23%
+11.3%
Q2 2020$429,000
+84.1%
5,844
+6.3%
0.20%
+111.5%
Q1 2020$233,000
-39.3%
5,497
-12.8%
0.10%
+52.4%
Q4 2019$384,0006,3060.06%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders